![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received for publication November 21, 2006.
Revised March 30, 2007.
Accepted for publication April 9, 2007.
)
Cytochrome P450 (CYP) eicosanoids regulate vascular tone, renal tubular transport, cellular proliferation and inflammation. Both the CYP4A
-hydroxylases, which catalyze 20-hydroxyeicosatetraenoic acid (20-HETE) formation, and soluble epoxide hydrolase (sEH), which catalyzes epoxyeicosatrienoic acid (EET) degradation to the dihydroxyeicosatrienoic acids (DHETs), are induced upon activation of peroxisome proliferator-activated receptor alpha (PPAR
) by fatty acids and fibrates. In contrast, the CYP2C epoxygenases, which are responsible for EET formation, are repressed after fibrate treatment. We show here that CYP eicosanoids can bind to and activate PPAR
and result in the modulation of PPAR
target gene expression. In transactivation assays, 14,15-DHET, 11,2-EET, and 20-HETE were potent activators of PPAR
. Gel shift assays showed that EETs, DHETs and 20-HETE induced PPAR
-specific binding to its cognate response element. Expression of apolipoprotein A-I was decreased 70% by 20-HETE whereas apolipoprotein A-II expression was increased up to 3-fold by 11,12-EET, 14,15-DHET, and 20-HETE. In addition, CYP eicosanoids induced CYP4A1, sEH, and CYP2C11 expression, suggesting that they can regulate their own levels. Given that CYP eicosanoids have multiple cardiovascular effects, pharmacological modulation of their formation and/or degradation may yield therapeutic benefits.
Key words:
CYP induction, CYP4, eicosanoids, nuclear receptors, peroxisome proliferator-activated receptors
This article has been cited by other articles:
![]() |
M. Fer, L. Corcos, Y. Dreano, E. Plee-Gautier, J.-P. Salaun, F. Berthou, and Y. Amet Cytochromes P450 from family 4 are the main omega hydroxylating enzymes in humans: CYP4F3B is the prominent player in PUFA metabolism J. Lipid Res., November 1, 2008; 49(11): 2379 - 2389. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. N. M. Zordoky, M. E. Aboutabl, and A. O. S. El-Kadi Modulation of Cytochrome P450 Gene Expression and Arachidonic Acid Metabolism during Isoproterenol-Induced Cardiac Hypertrophy in Rats Drug Metab. Dispos., November 1, 2008; 36(11): 2277 - 2286. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Antoun, S. Goulitquer, Y. Amet, Y. Dreano, J.-P. Salaun, L. Corcos, and E. Plee-Gautier CYP4F3B is induced by PGA1 in human liver cells: a regulation of the 20-HETE synthesis J. Lipid Res., October 1, 2008; 49(10): 2135 - 2141. [Abstract] [Full Text] [PDF] |
||||